Business
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for medical aesthetics and tissue regeneration, today announced that it will report financial results for the fourth quarter and full year of 2024 on Wednesday, March 26, 2025, before the opening of the U.S. financial markets. The Company will then host a conference call, the audio of which will be webcast to discuss its
About this update from Collplant Biotechnologies Ltd.
[{"type":"text","content":"Conference call to be held on Wednesday, March 26, 2025 at 10:00 a.m. U.S. EST","length":78,"tagName":"p","attribs":{}},{"type":"text","content":"REHOVOT, Israel, March 19, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for medical aesthetics and tissue regeneration, today announced that it will report financial results for the fourth quarter and full year of 2024 on Wednesday, March 26, 2025, before the opening of the U.S. financial markets. The Company will then host a conference call, the audio of which will be webcast to discuss its financial results and corporate updates on Wednesday, March 26th at 10:00 a.m. Eastern Standard Time.","length":656,"tagName":"p"},{"type":"text","content":" ","length":6,"tagName":"p"},{"type":"image","alt":"CollPlant logo","displaySize":"","headline":null,"caption":"CollPlant logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":152,"url":"https://media.zenfs.com/en/prnewswire.com/3a882eba3768734d4ad79a52f23e78eb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Deu5gzVrlZwpivr6btwn9w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTI2ODtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/3a882eba3768734d4ad79a52f23e78eb","width":400,"height":152}}},{"type":"text","content":" ","length":6,"tagName":"p"},{"type":"text","content":"Conference call information","length":27,"tagName":"p"},{"type":"text","content":"To participate in the conference call, please use the dial-in information below:","length":80,"tagName":"p"},{"type":"text","content":"U.S. investors: 1-877-407-9716 Investors outside of the U.S.: 1-201-493-6779 Israel investors: 1-809-406-247Conference ID: 13750725","length":144,"tagName":"p"},{"type":"text","content":"Note, you can avoid long wait times for the operator by using the Call me™ feature and clicking the link below 15 minutes prior to the scheduled call start time:","length":161,"tagName":"p"},{"type":"text","content":"https://callme.viavid.com/viavid/?callme=true&passcode=13728588&h=true&info=company-email&r=true&B=6","length":120,"tagName":"p"},{"type":"text","content":" ","length":6,"tagName":"p"},{"type":"text","content":" ","length":6,"tagN...